These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14616171)

  • 1. Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans.
    Coleman NS; Marciani L; Blackshaw E; Wright J; Parker M; Yano T; Yamazaki S; Chan PQ; Wilde K; Gowland PA; Perkins AC; Spiller RC
    Aliment Pharmacol Ther; 2003 Nov; 18(10):1039-48. PubMed ID: 14616171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study.
    Kusunoki H; Haruma K; Hata J; Kamada T; Ishii M; Yamashita N; Inoue K; Imamura H; Manabe N; Shiotani A
    J Gastroenterol; 2010 Dec; 45(12):1228-34. PubMed ID: 20658155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ondansetron on gastric tone and motility changes induced by a prolonged intraduodenal infusion of nutrients. Results of a placebo-controlled study.
    Savoye G; Brung-Lefebvre M; Bouin M; Maillot C; Denis P; Ducrotté P
    Dig Dis Sci; 2007 Oct; 52(10):2676-83. PubMed ID: 17393324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gastric acid suppressants on human gastric motility.
    Parkman HP; Urbain JL; Knight LC; Brown KL; Trate DM; Miller MA; Maurer AH; Fisher RS
    Gut; 1998 Feb; 42(2):243-50. PubMed ID: 9536950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study.
    Fujita T; Yokota S; Sawada M; Majima M; Ohtani Y; Kumagai Y
    J Clin Pharm Ther; 2005 Dec; 30(6):611-22. PubMed ID: 16336295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
    Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers.
    Verhagen MA; Samsom M; Maes B; Geypens BJ; Ghoos YF; Smout AJ
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1077-86. PubMed ID: 9663833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans.
    Camilleri M; Vazquez-Roque MI; Burton D; Ford T; McKinzie S; Zinsmeister AR; Druzgala P
    Neurogastroenterol Motil; 2007 Jan; 19(1):30-8. PubMed ID: 17187586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous infusion of glyceryl trinitrate on gastric and small intestinal motor function in healthy humans.
    Madsen JL; Fuglsang S; Graff J
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1251-7. PubMed ID: 16611287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
    Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial.
    Di Lorenzo C; Reddy SN; Villanueva-Meyer J; Mena I; Martin S; Hyman PE
    Gastroenterology; 1991 Dec; 101(6):1564-70. PubMed ID: 1955122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity.
    Stacher G; Bergmann H; Schneider C; Steiner-Mittelbach G; Gaupmann G; Steinringer H; Abatzi TA; Stacher-Janotta G
    Br J Clin Pharmacol; 1990 Jul; 30(1):41-8. PubMed ID: 2390431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
    Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
    Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral erythromycin on fasting and postprandial antroduodenal motility in patients with type I diabetes, measured with an ambulatory manometric technique.
    Samsom M; Jebbink RJ; Akkermans LM; Bravenboer B; vanBerge-Henegouwen GP; Smout AJ
    Diabetes Care; 1997 Feb; 20(2):129-34. PubMed ID: 9118759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sustained-release isosorbide dinitrate on post-prandial gastric emptying and gastroduodenal motility in healthy humans.
    Madsen JL; Rasmussen SL; Linnet J; Fuglsang S; Rumessen JJ
    J Int Med Res; 2004; 32(4):351-8. PubMed ID: 15303766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study.
    Dive A; Miesse C; Galanti L; Jamart J; Evrard P; Gonzalez M; Installé E
    Crit Care Med; 1995 Aug; 23(8):1356-62. PubMed ID: 7634805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic effects on human gastric motility.
    Parkman HP; Trate DM; Knight LC; Brown KL; Maurer AH; Fisher RS
    Gut; 1999 Sep; 45(3):346-54. PubMed ID: 10446101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of selective and non-selective muscarinic antagonists on gastrointestinal transit and bowel function in healthy women.
    Bharucha AE; Isowa H; Hiro S; Guan Z
    Neurogastroenterol Motil; 2013 Jan; 25(1):e35-43. PubMed ID: 23171069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5-HT receptors.
    Valdovinos MA; Thomforde GM; Camilleri M
    Aliment Pharmacol Ther; 1993 Feb; 7(1):61-6. PubMed ID: 7679934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.